CoChat

Lipoxins and novel 15‐epi‐lipoxin analogs display potent anti‐inflammatory actions after oral administration

Open access
Bannenberg, Gerard, Moussignac, Rose‐Laure, Gronert, Karsten, Devchand, Pallavi R, Schmidt, Birgitta A, Guilford, William J, Bauman, John G, Subramanyam, Babu, Daniel Perez, H, Parkinson, John F, Serhan, Charles N · 2004 · British Journal of Pharmacology
Cited by 138

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Lipoxins (LX) and aspirin‐triggered 15‐epi‐lipoxins (ATL) exert potent anti‐inflammatory actions. In the present study, we determined the anti‐inflammatory efficacy of endogenous LXA 4 and LXB 4, the stable ATL analog ATLa2, and a series of novel 3‐oxa‐ATL analogs (ZK‐996, ZK‐990, ZK‐994, and ZK‐142) after intravenous, oral, and topical administration in mice. LXA 4, LXB 4, ATLa2, and ZK‐994 were orally active, exhibiting potent systemic inhibition of zymosan A‐induced peritonitis at very low doses (50 ng kg−1–50 μ g kg−1). Intravenous ZK‐994 and ZK‐142 (500 μ g kg−1) potently attenuated hind limb ischemia/reperfusion‐induced lung injury, with 32±12 and 53±5% inhibition (P<0.05), respectively, of neutrophil accumulation in lungs. The same dose of ATLa2 had no significant protective action. Topical application of ATLa2, ZK‐994, and ZK‐142 (∼20 μ g cm−2) prevented vascular leakage and neutrophil infiltration in LTB 4/PGE 2‐stimulated ear skin inflammation. While ATLa2 and ZK‐142 displayed approximately equal anti‐inflammatory efficacy in this model, ZK‐994 displayed a slower onset of action. In summary, native LXA 4 and LXB 4, and analogs ATLa2, ZK‐142, and ZK‐994 retain broad anti‐inflammatory effects after intravenous, oral, and topical administration. The 3‐oxa‐ATL analogs, which have enhanced metabolic and chemical stability and a superior pharmacokinetic profile, provide new opportunities to explore the actions and therapeutic potential for LX and ATL. British Journal of Pharmacology (2004) 143, 43–52. doi:10.1038/sj.bjp.0705912

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0705912

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 138

Metadata

Authors
Bannenberg, G., Moussignac, R., Gronert, K., Devchand, P. R., Schmidt, B. A., Guilford, W. J., Bauman, J. G., Subramanyam, B., Daniel Perez, H., Parkinson, J. F., & Serhan, C. N.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2004-09
Volume
143
Issue
1
Pages
43-52
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2131368814
Cited by
138
References
1
FWCI
7.04
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipoxins and novel 15‐epi‐lipoxin analogs display potent anti‐inflammatory actions after oral administration. https://app.cochat.ai/papers/10.1038/sj.bjp.0705912
The paper
Bannenberg, G., Moussignac, R., Gronert, K., Devchand, P. R., Schmidt, B. A., Guilford, W. J., Bauman, J. G., Subramanyam, B., Daniel Perez, H., Parkinson, J. F., & Serhan, C. N. (2004). Lipoxins and novel 15‐epi‐lipoxin analogs display potent anti‐inflammatory actions after oral administration. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0705912

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.